- A Case of Infectious Mononucleosis
-
Lee JS, Kim DY
- KMID: 1964458
- Ewha Med J.
- 2001 Sep;24(3):131-135.
- doi: 10.12771/emj.2001.24.3.131
Infectious mononucleosis is an acute lymphoproliferative disease that is most common in children and young adults and is caused by Epstein-Barr virus. Characteristic clinical feastures include : 1) fever, sore throat,... -
- CITED
-
- Close
- SHARE
-
- Close
- CT Findings of Tuberculous Pneumonia in Diabetic Patients: Comparison with Tuberculosis in Nondiabetics
-
Kim Y, Park SW, Lee SM, Cho KS
- KMID: 1964455
- Ewha Med J.
- 2001 Sep;24(3):109-114.
- doi: 10.12771/emj.2001.24.3.109
OBJECTIVE: To evaluate the CT findings of pulmonary tuberculosis in diabetic patients compared with patients without underlying disease. METHODS: The chest CT scans of pulmonary tuberculosis in 23 diabetic patients(M :... -
- CITED
-
- Close
- SHARE
-
- Close
- Duplex and Doppler Ultrasonographic Findings of Renal Transplants: Focused on the Ewha Tondaemun Hospital Experiences
-
Yoo JH, Chung KY, Suh JS, Rhee CS
- KMID: 1964456
- Ewha Med J.
- 2001 Sep;24(3):115-121.
- doi: 10.12771/emj.2001.24.3.115
OBJECTIVE: Our purpose was to discuss the current results of renal transplantation at our institute and to document the usefulness of the ultrasonography in the follow-up of renal allograft. METHODS: Thirty... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Study on the Size of Hepatic Metastases Between Pre- and Postcontrast CT
-
Yoo JH, Suh JS, Rhee CS
- KMID: 1964457
- Ewha Med J.
- 2001 Sep;24(3):123-129.
- doi: 10.12771/emj.2001.24.3.123
OBJECTIVES: To investigate whether measurements of hepatic metastases before contrast administration are different from measuments after contrast administration. And to gain more effective follow up method by analyzing the difference... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy and Safety of Cerivastatin(LIPOBAY(R)) in Patients with Hypercholesterolemia
-
Park SH, Kim MY, Jung SJ, Lee YS, Park CH, Byun EK, Jeon SH
- KMID: 1964454
- Ewha Med J.
- 2001 Sep;24(3):103-108.
- doi: 10.12771/emj.2001.24.3.103
OBJECTIVES: Cerivastain(LIPOBAY(R)) is recently developed HMG-CoA reductase inhibitor which is effective in lowering serum cholesterol levels at microgram does. We evaluated the clinical efficacy and safety of cerivastatin(LIPOBAY(R)) in patients... -
- CITED
-
- Close
- SHARE
-
- Close
